Article
Anecortave acetate found to safe, effective for inhibiting CNV growthin AMD patients
Anecortave acetate (Retaane), a potent angiostatic agent, has been shownto be safe and superior to placebo in reducing loss of vision from baseline,avoiding severe vision loss, and inhibiting the growth of CNV membranesin patients with age-related macular degeneration (AMD), reported JasonS. Slakter, MD, who spoke during the American Academy of Ophthalmology annualmeeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
